Late Breaking Abstract - Comparative Effectiveness of Anti-IL5/5R Versus Anti-IgE in Patients Eligible for Both (FIRE)

N. Ali (Singapore, Singapore), J. Lyu (Singapore, Singapore), A. Newell (Singapore, Singapore), M. Sadatsafavi (Vancouver, British Columbia, Canada), T. Tran (MD, United States of America), D. Price (Aberdeen, United Kingdom)

Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Ali (Singapore, Singapore), J. Lyu (Singapore, Singapore), A. Newell (Singapore, Singapore), M. Sadatsafavi (Vancouver, British Columbia, Canada), T. Tran (MD, United States of America), D. Price (Aberdeen, United Kingdom). Late Breaking Abstract - Comparative Effectiveness of Anti-IL5/5R Versus Anti-IgE in Patients Eligible for Both (FIRE). 1113

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Late Breaking Abstract - Real-World Characteristics of Patients Receiving Dupilumab in Routine Clinical Practice in a Multinational, Non-Interventional Study (ProVENT)
Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science
Year: 2021


Late Breaking Abstract - SUPRAnav: A Clinical Trial Evaluating the Efficacy and Safety of a New Invention Device Designed for Continuous Supraglottic Aspiration in Mechanically Ventilated Patients.
Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Intensive care and infection
Year: 2019



Late Breaking Abstract - TriOptimize VIII – Improvement of Lung Function with Extrafine Single Inhaler Triple Therapy – Analysis of Response Patterns by Prior Treatment from a Real-World Study.
Source: Virtual Congress 2020 – Pharmacological management of COPD
Year: 2020


Late Breaking Abstract - Prone-Positioning in Awake, Non-Intubated Patients with COVID-19 Hypoxemic Failure: A Single-Center Trial
Source: Virtual Congress 2021 – Challenges of COVID-19 management at short and long-term
Year: 2021


Late Breaking Abstract - Bronchial Rheoplasty For Treatment of Chronic Bronchitis: 6 Month Results from a Prospective Multi-Center Study
Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: COPD and cough
Year: 2019



Late Breaking Abstract - Bronchoscopic Thermal Vapor Ablation (BTVA) Outcomes at 12 months in Emphysema Patients with Severe Hyperinflation, a STEP-UP RCT Subgroup Analysis
Source: International Congress 2017 – Late-breaking findings in asthma and COPD
Year: 2017

Late Breaking Abstract - Standard-of-Care Asthma Controller Regimen Reduction with Benralizumab Treatment: ANDHI In Practice Study
Source: Virtual Congress 2021 – Severe asthma: evaluation using patient-reported outcome measures (PROMs) and biomarkers, comorbidities and treatments
Year: 2021


Late Breaking Abstract - Exploring Efficacy and Safety of oral Pirfenidone for progressive, non-IPF Lung Fibrosis (RELIEF)
Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: Interstitial lung diseases and pulmonary hypertension
Year: 2019



Late Breaking Abstract - Blood Eosinophils as Predictor of Outcomes in hospitalized COPD Exacerbations: Results from a Prospective Study
Source: International Congress 2019 – Eosinophils and FeNO in airway diseases
Year: 2019



Late Breaking Abstract - Two Phase 3 Randomized Clinical Trials of Gefapixant, a P2X3 Receptor Antagonist, in Refractory or Unexplained Chronic Cough (COUGH-1 and COUGH-2)
Source: Virtual Congress 2020 – ALERT: Pneumothorax, cough, PAH, alveolar proteinosis
Year: 2020




Late Breaking Abstract - WEAning From NonInvasive Ventilation – ‘WEANIV’ Study
Source: Virtual Congress 2020 – ALERT: Ventilation and rehabilitation
Year: 2020



Late Breaking Abstract - A Pilot study of a novel Endoscopic Lung Volume Reduction device
Source: International Congress 2017 – Late-breaking findings in asthma and COPD
Year: 2017

Late Breaking Abstract - Clinical Efficacy and Safety of Macitentan Transitioned from Bosentan in Patients with Pulmonary Arterial Hypertension
Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension
Year: 2018




Late Breaking Abstract - Characteristics of Patients Diagnosed with Severe Asthma at UK Specialist Centres: Variation by Ethnicity
Source: International Congress 2019 – Bronchiectasis
Year: 2019

Late Breaking Abstract - Safety and Performance of Total Lung Access to Peripheral Nodules in prospective, multi-center study
Source: International Congress 2019 – Interventional pulmonology: a mixture of spices
Year: 2019



LSC - 2021 - Can Hematological Ratios Predict Outcome of COVID-19 Patients? Egyptian Multicentric Study.
Source: Virtual Congress 2021 – COVID19, acute respiratory failure and basic science
Year: 2021


Late Breaking Abstract - Does The High Use Of Oral Antiasthmatics Contribute To The Elevated Burden Of Asthma In India?
Source: International Congress 2019 – Blood eosinophils and more in airway diseases
Year: 2019




Late Breaking Abstract - Dry Powder Inhaler Preference in asthma patients. Results of the DPI PREFER Study
Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies
Year: 2020


Late Breaking Abstract - Patient Reported Outcomes (PRO) Correlate Better with Intra-Breath than with Whole-Breath FOT Parameters.
Source: International Congress 2017 – Late-breaking findings in asthma and COPD
Year: 2017

Late Breaking Abstract - Effects of a new Airway Clearance Technology versus manual physiotherapy in COPD
Source: International Congress 2018 – Functional assessment of COPD
Year: 2018